2017
DOI: 10.1016/j.jcrs.2017.05.030
|View full text |Cite
|
Sign up to set email alerts
|

Accelerated 15 mW pulsed-light crosslinking to treat progressive keratoconus: Two-year clinical results

Abstract: The 15 mW/cm pulsed-light epithelium-off accelerated CXL was effective and safe, stabilizing keratoconus progression through 2 years of follow-up.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
39
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 50 publications
(39 citation statements)
references
References 21 publications
0
39
0
Order By: Relevance
“…Because of the progressive nature of myopia in most of these patients, the efficacy of the procedure decreases with time [15]. Corneal diseases such as keratoconus or development of cataracts may also induce progression of myopia [16]. However preoperative corneal topography was normal in all eyes and cataracts did not developed in any eye.…”
Section: Discussionmentioning
confidence: 99%
“…Because of the progressive nature of myopia in most of these patients, the efficacy of the procedure decreases with time [15]. Corneal diseases such as keratoconus or development of cataracts may also induce progression of myopia [16]. However preoperative corneal topography was normal in all eyes and cataracts did not developed in any eye.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the 9mW/cm 2 A-CXL was safe for corneal endothelium, stabilizing the progression of keratoconus and iatrogenic ectasia with a significant reduction in topographic keratometry values and a significant increase in CDVA, comparable with conventional 3mW/cm 2 CXL in a mid-term (two-years) follow-up. 63 Mazzotta et al 73 documented the clinical and microstructural IVCM and OCT results of accelerated 15mW/cm 2 pulsed-light corneal crosslinking (CXL) in progressive KC showing a distinct DL at 280 ±30 µm depth on average. The 15mW/cm 2 pulsed-light epithelium-off A-CXL confirmed the laboratory data of Krueger et al 72 demonstrating the safety and the clinical efficacy of this protocol in stabilizing KC progression through 2 years of follow-up.…”
Section: -Dmentioning
confidence: 99%
“…Because the Dresden protocol requires a long treatment time of 60 minutes, accelerated protocols have been proposed to shorten the treatment time [103][104][105][106]. Recent studies include evaluations of pulsed or fractionated UV-A protocols in order to improve the effectiveness of accelerated protocols 107. Current treatment protocols require either the removal of the epithelium or exposure of the intact epithelium to agents that increase the permeability of the cell layer, followed by the application of topical riboflavin and UV-A treatment.…”
mentioning
confidence: 99%